Company Filing History:
Years Active: 1976
Title: Albert L Vulcano: Innovator in Pharmaceutical Chemistry
Introduction
Albert L Vulcano is a notable inventor based in Liverpool, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of valuable intermediates for semi-synthetic cephalosporins. His work has implications for the development of important antibiotics.
Latest Patents
Albert L Vulcano holds a patent for a process for the preparation of 7-aminocephalosporanic acids. This patent outlines a method for producing 7-aminocephalosporanic acid (7-ACA) and 7-amino-3-methyl-3-cephem-4-carboxylic acid (7-ADCA). These compounds are essential intermediates in the synthesis of semi-synthetic cephalosporins. The invention claims the use of dicyclohexylamine or diisopropylamine as a substitute for a tertiary amine acid scavenger in the halogenation step of the process.
Career Highlights
Albert L Vulcano is associated with Bristol-Myers Company, where he has contributed to advancements in pharmaceutical research and development. His innovative approach to chemical processes has led to the successful formulation of key compounds used in antibiotic therapies.
Collaborations
Throughout his career, Albert has collaborated with esteemed colleagues, including David A Johnson and Steven P Brundidge. These partnerships have fostered a collaborative environment that enhances the research and development of pharmaceutical innovations.
Conclusion
Albert L Vulcano's contributions to the field of pharmaceutical chemistry, particularly through his patent on the preparation of 7-aminocephalosporanic acids, highlight his role as an innovator in the industry. His work continues to impact the development of essential antibiotics, showcasing the importance of innovation in healthcare.